➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School

Last Updated: October 21, 2021

DrugPatentWatch Database Preview

Litigation Details for Amarin Pharma, Inc. v. Apotex, Inc. (N.D. Ill. 2014)

Email this page to a colleague

« Back to Dashboard

Amarin Pharma, Inc. v. Apotex, Inc. (N.D. Ill. 2014)

Docket ⤷  Try it Free Date Filed 2014-04-24
Court District Court, N.D. Illinois Date Terminated 2014-08-27
Cause 35:271 Patent Infringement Assigned To James F. Holderman
Jury Demand None Referred To
Patents 8,293,728; 8,318,715; 8,357,677; 8,367,652; 8,377,920; 8,399,446; 8,415,335; 8,426,399; 8,431,560; 8,440,650; 8,501,225; 8,518,929; 8,524,698; 8,546,372; 8,551,521; 8,617,594
Firms Stack & O'Connor Chartered
Link to Docket External link to docket
Small Molecule Drugs cited in Amarin Pharma, Inc. v. Apotex, Inc.
The small molecule drug covered by the patents cited in this case is ⤷  Try it Free .

Details for Amarin Pharma, Inc. v. Apotex, Inc. (N.D. Ill. 2014)

Date Filed Document No. Description Snippet Link To Document
2014-04-24 1 of U.S. Patent No. 8,293,728 (“the ‘728 Patent”), U.S. Patent No. 8,318,715 (“the ‘715 Patent”), U.S.…36 above. 38. United States Patent No. 8,293,728, entitled “METHODS OF TREATING HYPERTRIGLYCERIDEMIA…U.S. Patent No. 8,357,677 (“the ‘677 Patent”), U.S. Patent No. 8,367,652 (“the ‘652 Patent”), U.S. Patent…,920 (“the ‘920 Patent”), U.S. Patent No. 8,399,446 (“the ‘446 Patent”), U.S. Patent No. 8,415,335 (“…(“the ‘335 Patent”), U.S. Patent No. 8,426,399 (“the ‘399 Patent”), U.S. Patent No. 8,431,560 (“the External link to document
2014-04-30 7 Amarin Pharmaceuticals Ireland Limited US 8,318,715 B2 11/27/2012 …451 Patent Number Date of Patent Holder of Patent US 8,617,594… MAILED patent report to Patent Trademark Office, Alexandria VA. (vcf, ) (Entered: 04/30/2014) … Apotex, Inc. PATENT NUMBER DATE OF PATENT … of 2 PageID #:450 TO: COMMISSIONER OF PATENTS AND TRADEMARKS (USPTO) External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.